Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma | NeoGenomics Laboratories

Publication date

Tue, 10/11/2022 - 12:00

Category

Year

Subtitle

ESMO 2022

File

LBx_for_detection_of_molecular_residual_disease_ESMO_2022.pdf (1.58 MB)

Division